Lataa...
Pharmacotherapy of mild cognitive impairment
Amnestic mild cognitive impairment (MCI) can be considered as a state with a high risk of developing Alzheimer's disease within 5 years, or as a prodromal stage of this condition. Randomized clinical trials comparing the acetylcholinesterase inhibitor donepezil with placebo have shown some symp...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Les Laboratoires Servier
2004
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3181817/ https://ncbi.nlm.nih.gov/pubmed/22034396 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|